Gilad Oren (CIK 1929300) reported 4 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-03-16). Recent activity: Buy APRE (20,175 shares), Buy APRE (28,100 shares), Buy APRE (3,003 shares), Buy APRE (2,497 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-16 | Aprea Therapeutics, Inc. (APRE) | President/CEO | Buy | 20,175 | $0 |
| 2026-02-02 | Aprea Therapeutics, Inc. (APRE) | President/CEO | Buy | 28,100 | $25,009 |
| 2025-04-04 | Aprea Therapeutics, Inc. (APRE) | President/CEO | Buy | 3,003 | $5,616 |
| 2025-04-04 | Aprea Therapeutics, Inc. (APRE) | President/CEO | Buy | 2,497 | $4,495 |
来源：SEC Form 4 申报文件 · 截至 2026-03-16